The Rise of App-Device Combination Products in MedTech

The boundary between medical devices and digital health applications has dissolved. Today's most successful medical products are not standalone hardware or standalone software. They are combination products that pair a physical device with a companion digital health application to create an integrated clinical experience. From Dexcom's G7 continuous glucose monitor paired with its Clarity app to Medtronic's InPen smart insulin delivery system with its Sugar.IQ companion, the app-device combination model is redefining how medical technology is designed, regulated, marketed, and adopted.

This convergence is driven by three forces. First, clinicians demand data. A device that generates clinical measurements is valuable; a device that generates measurements, transmits them to the EHR, displays trends, and triggers alerts is transformative. Second, patients expect connected experiences. Consumer electronics have trained patients to expect their health devices to sync with their phones as seamlessly as their fitness trackers. Third, payers require evidence. Value-based care models reward outcomes, and app-device combinations generate the longitudinal data needed to demonstrate those outcomes.

The numbers confirm the trend. The digital therapeutics market, which relies heavily on app-device combinations, is projected to reach $13.5 billion by 2027. Connected medical device shipments exceeded 380 million units globally in 2024. The FDA has cleared or approved over 700 AI and machine learning-enabled medical devices, many of which include companion applications.

For manufacturers navigating this landscape, marketing an app-device combination product requires a fundamentally different approach than marketing either component alone. This article covers the regulatory framework, positioning strategy, content approach, and channel considerations that drive successful combination product marketing.

Regulatory Framework for Combination Product Marketing

Marketing claims for app-device combinations must navigate a regulatory framework that treats the device and software components differently depending on their classification, intended use, and risk level.

FDA Classification Considerations

The FDA classifies combination products based on their primary mode of action. A glucose monitor with a companion app might be regulated primarily as a Class II medical device under the device CDRH pathway, with the app considered a component of the device. Alternatively, if the app includes independent clinical decision support features, it may require separate regulatory consideration.

The 2023 FDA guidance on "Clinical Decision Support Software" distinguishes between software functions that are regulated as medical devices and those that are exempt. Marketing teams must understand exactly which claims are supported by the product's regulatory clearance and which fall outside the cleared indications for use.

This matters practically because marketing materials frequently describe app features that go beyond the device's 510(k) clearance. If your device is cleared for measuring blood pressure, but your app includes an AI algorithm that predicts hypertensive events, that predictive feature may require separate regulatory authorization. Marketing claims about the predictive feature before clearance could trigger FDA enforcement action.

Promotional Review Processes

Establish a promotional review process that evaluates combination product marketing materials against both the device's cleared indications and the app's regulatory status. This process should involve regulatory affairs, legal, medical affairs, and marketing working collaboratively to ensure claims are substantiated and compliant.

Many companies establish a Medical Legal Regulatory (MLR) review committee specifically for combination product marketing. This committee reviews all promotional materials, including website content, app store descriptions, social media posts, and sales presentations, before public distribution.

App Store Compliance

App store listings present unique regulatory challenges. Apple's App Store and Google Play have their own policies regarding health claims, and these policies sometimes conflict with FDA requirements. Additionally, app store descriptions are public-facing promotional materials subject to FDA scrutiny. Ensure that app store listings accurately reflect the app's cleared functionality without making unsupported clinical claims.

Positioning Strategy for Combination Products

Positioning an app-device combination product requires integrating the value propositions of both components into a unified narrative that resonates with multiple audiences. Our medical device marketing guide provides broader context for positioning strategy within the medtech industry.

The Integrated Experience Narrative

The most effective positioning for combination products emphasizes the integrated experience rather than listing device specs and app features separately. Patients and clinicians do not think in terms of "hardware plus software." They think in terms of outcomes, convenience, and clinical value.

Consider Dexcom's positioning. They do not market the G7 sensor and the Clarity app as separate products. They market a continuous glucose monitoring system that provides real-time glucose readings, trend arrows, customizable alerts, and shareable reports, all as one seamless experience. The hardware and software are inseparable in the user's mind, which is exactly the right positioning.

Multi-Stakeholder Messaging

Combination products typically require approval or endorsement from multiple stakeholders, each with different priorities.

Develop messaging matrices that map key claims and proof points to each stakeholder audience. This ensures consistency while allowing targeted communication.

Competitive Differentiation

In categories where multiple manufacturers offer app-device combinations, differentiation often comes from the software experience rather than the hardware. When sensor accuracy or device form factors are comparable across competitors, the app's usability, data visualization, integration capabilities, and patient engagement features become the primary differentiators.

This shifts the competitive conversation from traditional device metrics (accuracy, size, battery life) to digital product metrics (user retention, daily active users, feature adoption rates). Marketing teams must be prepared to compete on both fronts.

Content Marketing for App-Device Products

Content marketing for combination products must educate audiences about both the clinical value and the digital experience. This dual mandate requires a content strategy that goes beyond traditional medical device content.

Clinical Evidence Content

Publish content that demonstrates how the combination product improves outcomes compared to device-only or app-only alternatives. This might include peer-reviewed study summaries, real-world evidence reports, and clinical case studies showing how the integrated product changed patient management in practice.

Effective healthcare SEO ensures this clinical content reaches physicians searching for evidence-based solutions to specific clinical challenges.

User Experience Content

Create content that showcases the app experience through screenshots, video walkthroughs, and user testimonials. This content serves both clinician and patient audiences by demonstrating that the product is not just clinically effective but also practical to use in daily life.

Video content is particularly effective for combination products because it can demonstrate the seamless interaction between device and app in real-time. A 90-second video showing a patient applying a monitoring patch, watching data appear on their phone, and sharing a report with their physician during a telehealth visit communicates more value than a page of written specifications.

Technical Integration Content

For IT decision-makers and platform partners, create technical content covering API documentation, data format specifications, security architecture, and integration workflows. This content positions your product as enterprise-ready and reduces perceived implementation risk.

Patient Education Content

Patients using app-device combinations need education content that covers device setup, app installation, pairing procedures, data interpretation, troubleshooting, and when to contact their healthcare provider based on app alerts. This content reduces support burden and improves patient adherence.

Structure patient education as a progressive curriculum. Start with basic setup content, then advance to interpretation guides, condition management tips, and advanced feature tutorials. This approach mirrors the patient's learning journey and keeps them engaged with the product over time.

Digital Marketing Channels for Combination Products

The dual nature of app-device combination products opens marketing channels that are not available to traditional device manufacturers.

App Store Optimization

If your combination product includes a downloadable companion app, app store optimization (ASO) becomes a critical marketing channel. Optimize your app listing with relevant keywords, compelling screenshots, clear feature descriptions, and active review management. A well-optimized app store listing can drive organic downloads that translate into device sales.

Monitor app store reviews closely. Negative reviews about app crashes, connectivity issues, or confusing interfaces directly impact device sales and clinician confidence. Respond to reviews promptly and use feedback to inform product improvements.

Social Media and Patient Community Marketing

Connected health products naturally generate social sharing behavior. Patients share their health data, celebrate milestones, and support each other in online communities. Create social media strategies that encourage and amplify this organic sharing while remaining HIPAA-compliant.

Diabetes management is the gold standard for community-driven combination product marketing. The #WeAreNotWaiting movement, CGM data-sharing communities, and patient advocacy groups have created a vibrant ecosystem that manufacturers can participate in authentically.

Digital Advertising

Combination products can leverage both device-focused and app-focused advertising strategies. Run device-awareness campaigns through traditional medtech channels (medical journals, conference sponsorships, KOL engagement) while simultaneously running app-download campaigns through digital channels (social media advertising, search marketing, influencer partnerships).

The key is coordinating these campaigns so that a clinician who sees a device ad at a medical conference and a patient who downloads the app from an Instagram ad both encounter a consistent brand experience.

Email and CRM Marketing

App-device combinations generate rich user engagement data that enables sophisticated email marketing and CRM strategies. When a patient activates a device and pairs it with the app, you know their diagnosis, usage patterns, engagement level, and clinical context. Use this data responsibly to deliver personalized content, feature announcements, and re-engagement campaigns.

User Experience as a Marketing Strategy

For combination products, the user experience is the marketing strategy. A mediocre app paired with a great device will underperform a great app paired with an adequate device. Consumer expectations, shaped by companies like Apple and Google, mean that patients judge medical apps against the same usability standards they apply to banking apps and food delivery services.

Onboarding Experience

The first 10 minutes of a patient's experience with your combination product determine long-term engagement. A smooth onboarding flow that guides the patient from unboxing to first reading creates positive sentiment and reduces early abandonment. A confusing onboarding experience generates support calls, negative reviews, and clinician frustration.

Invest in user research, usability testing, and onboarding optimization as marketing activities, not just product development activities. Every dollar spent improving the first-use experience reduces customer acquisition costs by decreasing churn and increasing word-of-mouth referrals.

Ongoing Engagement Design

The app component of your combination product is not a one-time purchase. It is an ongoing relationship with the patient. Design engagement features that provide continuous value: personalized insights, progress tracking, educational content, refill reminders, and caregiver sharing. These features improve clinical outcomes while simultaneously increasing the lifetime value of each patient relationship.

Accessibility

Medical apps must be accessible to patients with visual impairments, motor limitations, and cognitive challenges. Accessibility is not just a regulatory requirement under the ADA. It is a marketing differentiator. An app that works well for patients with limited dexterity or vision expands your addressable market and demonstrates genuine patient-centricity.

Health Economics and Value Demonstration

Payers increasingly require health economic evidence to approve coverage for combination products. Develop value dossiers that quantify the economic impact of your integrated product, including direct cost savings (reduced office visits, fewer complications, shorter hospital stays), indirect cost savings (reduced absenteeism, improved productivity), and quality of life improvements (patient-reported outcomes).

The most compelling health economic evidence for combination products demonstrates that the integrated solution delivers better outcomes at lower total cost than the device alone, the app alone, or the current standard of care. This comparative evidence is essential for formulary placement and coverage decisions.

Our medical device marketing services include health economic messaging development for manufacturers seeking to communicate value to payer audiences.

Lifecycle Marketing for Combination Products

Combination products have unique lifecycle marketing requirements because the software component can be updated independently of the hardware. This creates opportunities for ongoing feature marketing, re-engagement campaigns, and upgrade messaging that do not exist for traditional devices.

Feature Launch Marketing

Each significant app update is a marketing opportunity. When you add a new data visualization, integrate with a new EHR platform, or launch a patient education module, promote these updates to existing users and use them as selling points for new customer acquisition. Feature launches keep your product in the conversation and demonstrate ongoing investment in the platform.

Hardware Refresh Marketing

When you launch next-generation hardware, existing app users represent a highly qualified prospect pool. They are already engaged with your ecosystem, familiar with your brand, and likely to upgrade if the new device offers meaningful improvements. Target these users with upgrade campaigns that emphasize how the new hardware enhances the app experience they already value.

End-of-Life Communication

When hardware reaches end of life or app platforms drop support for older operating systems, clear communication is essential. Patients depend on these products for health management. Abrupt discontinuation damages trust and brand reputation. Develop transition plans with generous notice periods, clear migration paths, and support resources.

Measuring Marketing Success for Combination Products

Traditional medical device marketing metrics (units shipped, revenue per rep, congress leads) remain relevant but are insufficient for combination products. Add digital product metrics to create a comprehensive view of marketing performance.

Looking Ahead: The Future of App-Device Combinations

The app-device combination model is expanding into new therapeutic areas and device categories. Surgical instruments with companion planning apps, implantable devices with patient monitoring apps, and diagnostic equipment with AI-powered interpretation apps are all following the path blazed by CGMs and connected inhalers.

Manufacturers that invest now in building the marketing capabilities, regulatory expertise, and organizational structures needed to market combination products will have a significant advantage as this model becomes the industry standard rather than the exception. The future of medical devices is not hardware or software. It is hardware and software, marketed as one integrated clinical solution.